首页 > 最新文献

Applied radiation oncology最新文献

英文 中文
Milestones and Master Plans 里程碑和总体规划
Pub Date : 2023-06-01 DOI: 10.37549/aro1342
J. Suh
{"title":"Milestones and Master Plans","authors":"J. Suh","doi":"10.37549/aro1342","DOIUrl":"https://doi.org/10.37549/aro1342","url":null,"abstract":"","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41478591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Whole-Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases: Single-Institution Prospective Clinical Trial 儿童和成人滑膜肉瘤和肺转移的全肺IMRT:单机构前瞻性临床试验
Pub Date : 2023-06-01 DOI: 10.37549/aro1344
Brianna Conte, D. Casey, N. Gerber, L. Wexler, K. Alektiar, S. Berry, S. Wolden
{"title":"Whole-Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases: Single-Institution Prospective Clinical Trial","authors":"Brianna Conte, D. Casey, N. Gerber, L. Wexler, K. Alektiar, S. Berry, S. Wolden","doi":"10.37549/aro1344","DOIUrl":"https://doi.org/10.37549/aro1344","url":null,"abstract":"","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45757660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opportunities Are Knocking, Are You Listening? 机会在敲门,你在听吗?
Pub Date : 2023-06-01 DOI: 10.37549/aro1341
K. McComas
{"title":"Opportunities Are Knocking, Are You Listening?","authors":"K. McComas","doi":"10.37549/aro1341","DOIUrl":"https://doi.org/10.37549/aro1341","url":null,"abstract":"","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44635334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the Utility of Webinars on the Radiation Oncology Residency Application Process in the COVID-19 Era 评估网络研讨会在COVID-19时代放射肿瘤学住院医师申请过程中的效用
Pub Date : 2023-06-01 DOI: 10.37549/aro1339
N. Razavian, Alexis N. Schutz, L.-T. Chang, Cecil Benitez, M. Sandoval, Y. Sharifzadeh, M. Sherer, E. Merfeld, C. Washington, G. McKenzie, Q. Khan, C. Hassanzadeh, Mona Arbab
{"title":"Evaluating the Utility of Webinars on the Radiation Oncology Residency Application Process in the COVID-19 Era","authors":"N. Razavian, Alexis N. Schutz, L.-T. Chang, Cecil Benitez, M. Sandoval, Y. Sharifzadeh, M. Sherer, E. Merfeld, C. Washington, G. McKenzie, Q. Khan, C. Hassanzadeh, Mona Arbab","doi":"10.37549/aro1339","DOIUrl":"https://doi.org/10.37549/aro1339","url":null,"abstract":"","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47712709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Vision Loss From Radiation-Induced Optic Neuropathy Resulting in Charles Bonnet Syndrome Charles Bonnet综合征引起的辐射性视神经病变导致的视力损失1例
Pub Date : 2023-06-01 DOI: 10.37549/aro1340
S. K. Sandstrom, David B. Mansur, M. L. Morgan, Serah Choi
region. The patient underwent a near total resection of the tumor and pathology showed a CNS WHO grade 2 meningioma. One month following surgery, she completed conventionally fractionated radiation therapy to the residual tumor and surrounding high-risk region using proton beam therapy to a total dose of 50.4 cobalt gray equivalents (CGE) in 28 fractions (1.8 CGE per fraction) (Figure 1) . In the absence of an established dose response and given the proximity of the optic apparatus and the emerging uncertainty about proton relative biological effectiveness (RBE) and radiation injury, a dose of 50.4 CGE was used. The maximum (to 0.03 cc volume) and mean doses to the optic nerves and chiasm were: right Abstract Radiation-induced optic neuropathy (RION) is a rare late effect following radiation caused by damage to the optic nerves or chiasm. It is a profound and devastating complication of radiation therapy with no effective treatment and is irreversible. Charles Bonnet syndrome (CBS) is a rare phenomenon characterized by complex visual hallucinations that occur concurrently with visual field loss or visual acuity loss. This case describes a woman with a CNS WHO grade 2 meningioma who received conventionally fractionated radiation therapy with a proton beam to the residual tumor and resection cavity after near total resection. She subsequently developed RION with vision loss and hallucinations and was diagnosed with CBS. We recommend that even though the incidence of RION is rare, patients should be counseled by providers for potential late effects of radiation treatment with surveillance routinely after treatment.
区域患者接受了肿瘤的近全切除术,病理显示为中枢神经系统世界卫生组织2级脑膜瘤。手术后一个月,她完成了对残留肿瘤和周围高危区域的常规分级放射治疗,使用质子束治疗,总剂量为50.4钴灰当量(CGE),分为28个部分(每个部分1.8 CGE)(图1)。在没有确定剂量反应的情况下,考虑到光学装置的邻近性以及质子相对生物有效性(RBE)和辐射损伤的不确定性,使用50.4 CGE的剂量。视神经和视交叉的最大剂量(至0.03cc体积)和平均剂量为:右摘要辐射诱导的视神经病变(RION)是由视神经或视交叉损伤引起的辐射后罕见的晚期效应。它是放射治疗的一种严重而毁灭性的并发症,没有有效的治疗方法,而且是不可逆转的。Charles Bonnet综合征(CBS)是一种罕见的现象,其特征是复杂的幻觉与视野丧失或视力丧失同时发生。该病例描述了一名患有中枢神经系统世界卫生组织2级脑膜瘤的女性,她在近全切除后接受了常规分割放射治疗,用质子束照射残留肿瘤和切除腔。随后,她患上了RION,伴有视力下降和幻觉,并被诊断为CBS。我们建议,即使RION的发生率很低,患者也应接受放射治疗提供者的建议,了解放射治疗的潜在后期影响,并在治疗后进行常规监测。
{"title":"A Case of Vision Loss From Radiation-Induced Optic Neuropathy Resulting in Charles Bonnet Syndrome","authors":"S. K. Sandstrom, David B. Mansur, M. L. Morgan, Serah Choi","doi":"10.37549/aro1340","DOIUrl":"https://doi.org/10.37549/aro1340","url":null,"abstract":"region. The patient underwent a near total resection of the tumor and pathology showed a CNS WHO grade 2 meningioma. One month following surgery, she completed conventionally fractionated radiation therapy to the residual tumor and surrounding high-risk region using proton beam therapy to a total dose of 50.4 cobalt gray equivalents (CGE) in 28 fractions (1.8 CGE per fraction) (Figure 1) . In the absence of an established dose response and given the proximity of the optic apparatus and the emerging uncertainty about proton relative biological effectiveness (RBE) and radiation injury, a dose of 50.4 CGE was used. The maximum (to 0.03 cc volume) and mean doses to the optic nerves and chiasm were: right Abstract Radiation-induced optic neuropathy (RION) is a rare late effect following radiation caused by damage to the optic nerves or chiasm. It is a profound and devastating complication of radiation therapy with no effective treatment and is irreversible. Charles Bonnet syndrome (CBS) is a rare phenomenon characterized by complex visual hallucinations that occur concurrently with visual field loss or visual acuity loss. This case describes a woman with a CNS WHO grade 2 meningioma who received conventionally fractionated radiation therapy with a proton beam to the residual tumor and resection cavity after near total resection. She subsequently developed RION with vision loss and hallucinations and was diagnosed with CBS. We recommend that even though the incidence of RION is rare, patients should be counseled by providers for potential late effects of radiation treatment with surveillance routinely after treatment.","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47787188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stereotactic Radiosurgery for Brain Metastases: Review of Existing Data and Future Directions 脑转移瘤的立体定向放射外科:现有资料和未来方向的回顾
Pub Date : 2023-06-01 DOI: 10.37549/aro1338
E. Rahimy, S. Soltys
appropriate for SRS over WBRT techniques? What is the best sequencing of
适用于SRS而非WBRT技术?什么是最好的排序
{"title":"Stereotactic Radiosurgery for Brain Metastases: Review of Existing Data and Future Directions","authors":"E. Rahimy, S. Soltys","doi":"10.37549/aro1338","DOIUrl":"https://doi.org/10.37549/aro1338","url":null,"abstract":"appropriate for SRS over WBRT techniques? What is the best sequencing of","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48641654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stanford Experience With Commissioning, Quality Assurance and IMRT/ SBRT Treatment of the First Biology-Guided Radiation Therapy Machine 斯坦福大学第一台生物引导放射治疗机的调试、质量保证和IMRT/SBRT治疗经验
Pub Date : 2023-06-01 DOI: 10.37549/aro1343
B. Han, N. Kovalchuk, M. Gensheimer, L. Vitzthum, L. Xing, M. Surucu
formed by all MLC leaves retracted is 40 cm. The jaw pairs open 1 or 2 cm at the isocenter in the longitudinal direction. The nominal beam dose rate is 850 monitor units (MU)/min for the original IMRT/SBRT version of the machine. With the BgRT upgrade, the dose rate is 1000 MU/ min. The kVCT scanner is located on a plane 61.4 cm superior to the room laser. The X1 machine consists of 2 symmetrically opposing 90-degree arcs of PET detectors incorporated into the architecture of a ring-gantry at the same plane to the linac 100 cm superior to the room laser. The treatment delivery with the X1 system is achieved axially with the couch advancing at discrete intervals of 2.1 mm, making 1 or 4 passes through the treated region Abstract Biology-guided radiation therapy (BgRT) is an emerging technology that integrates real-time PET imaging with radiation therapy to improve tumor targeting and treatment outcomes. This systematic review aims to summarize the Stanford experience on the current state of knowledge on machine commissioning, quality assurance, treat-ment planning, clinical applications, safety, and efficacy of BgRT in cancer treatment. The review underscores advancements in the clinical implementation of intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) technologies, facilitated by the introduction of the novel BgRT machine. It also highlights challenges related to improving workflow efficiency and validating tracking accuracy in real-world patient situations. This document serves as a valuable resource for researchers, clinicians, and decision-makers within the realm of radiation oncology, providing insights into the status of the PET-based BgRT machine and guiding the trajectory of future research.
所有MLC叶片收缩形成的间隙为40厘米。钳口对在纵向等中心处张开1或2厘米。对于机器的原始IMRT/SBRT版本,标称射束剂量率为850监测器单位(MU)/min。BgRT升级后,剂量率为1000 MU/min。kVCT扫描仪位于比房间激光器高61.4厘米的平面上。X1机器由两个对称相对的90度PET探测器弧组成,这些探测器被纳入环形龙门架的结构中,位于直线加速器的同一平面上,比室内激光器高100厘米。X1系统的治疗递送是在床以2.1毫米的离散间隔轴向推进的情况下实现的,使1或4次通过治疗区域摘要生物学引导的放射治疗(BgRT)是一种新兴技术,它将实时PET成像与放射治疗相结合,以提高肿瘤靶向性和治疗效果。本系统综述旨在总结斯坦福大学在机器调试、质量保证、治疗计划、临床应用、安全性和BgRT在癌症治疗中的有效性方面的知识现状方面的经验。这篇综述强调了新型BgRT机器的引入促进了调强放射治疗(IMRT)和立体定向身体放射治疗(SBRT)技术的临床应用进展。它还强调了在现实世界患者情况下提高工作流程效率和验证跟踪准确性的挑战。本文件为放射肿瘤学领域的研究人员、临床医生和决策者提供了宝贵的资源,深入了解了基于PET的BgRT机器的现状,并指导了未来的研究轨迹。
{"title":"Stanford Experience With Commissioning, Quality Assurance and IMRT/ SBRT Treatment of the First Biology-Guided Radiation Therapy Machine","authors":"B. Han, N. Kovalchuk, M. Gensheimer, L. Vitzthum, L. Xing, M. Surucu","doi":"10.37549/aro1343","DOIUrl":"https://doi.org/10.37549/aro1343","url":null,"abstract":"formed by all MLC leaves retracted is 40 cm. The jaw pairs open 1 or 2 cm at the isocenter in the longitudinal direction. The nominal beam dose rate is 850 monitor units (MU)/min for the original IMRT/SBRT version of the machine. With the BgRT upgrade, the dose rate is 1000 MU/ min. The kVCT scanner is located on a plane 61.4 cm superior to the room laser. The X1 machine consists of 2 symmetrically opposing 90-degree arcs of PET detectors incorporated into the architecture of a ring-gantry at the same plane to the linac 100 cm superior to the room laser. The treatment delivery with the X1 system is achieved axially with the couch advancing at discrete intervals of 2.1 mm, making 1 or 4 passes through the treated region Abstract Biology-guided radiation therapy (BgRT) is an emerging technology that integrates real-time PET imaging with radiation therapy to improve tumor targeting and treatment outcomes. This systematic review aims to summarize the Stanford experience on the current state of knowledge on machine commissioning, quality assurance, treat-ment planning, clinical applications, safety, and efficacy of BgRT in cancer treatment. The review underscores advancements in the clinical implementation of intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) technologies, facilitated by the introduction of the novel BgRT machine. It also highlights challenges related to improving workflow efficiency and validating tracking accuracy in real-world patient situations. This document serves as a valuable resource for researchers, clinicians, and decision-makers within the realm of radiation oncology, providing insights into the status of the PET-based BgRT machine and guiding the trajectory of future research.","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48066937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Future of Radiation Oncology Education: Transforming Scholarly Teaching Into Medical Education Scholarship 放射肿瘤学教育的未来:将学术教学转化为医学教育奖学金
Pub Date : 2023-03-01 DOI: 10.37549/aro1334
A. Saraf, G. Boyd, A. D. De Leo, P. Gawu, C. Pinnix, Steve E. Braunstein, R. Jimenez, I. Franco, L. Singer
{"title":"Future of Radiation Oncology Education: Transforming Scholarly Teaching Into Medical Education Scholarship","authors":"A. Saraf, G. Boyd, A. D. De Leo, P. Gawu, C. Pinnix, Steve E. Braunstein, R. Jimenez, I. Franco, L. Singer","doi":"10.37549/aro1334","DOIUrl":"https://doi.org/10.37549/aro1334","url":null,"abstract":"","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43514000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Locoregional Chemoradiation for a Patient with BRCA1 Stage IV Pancreatic Adenocarcinoma BRCA1期IV期胰腺腺癌患者的局部放化疗
Pub Date : 2023-03-01 DOI: 10.37549/aro1335
Pranit Singh, Jacob Adams, Sylvia Choo, M. Adams, J. McDonald, Laura Barton, R. Levine, D. W. Kim, R. Palm, J. Frakes, Sarah Hoffe
{"title":"Locoregional Chemoradiation for a Patient with BRCA1 Stage IV Pancreatic Adenocarcinoma","authors":"Pranit Singh, Jacob Adams, Sylvia Choo, M. Adams, J. McDonald, Laura Barton, R. Levine, D. W. Kim, R. Palm, J. Frakes, Sarah Hoffe","doi":"10.37549/aro1335","DOIUrl":"https://doi.org/10.37549/aro1335","url":null,"abstract":"","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41952232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Boswellia Serrata in Management of CNS Radiation Necrosis After Radiosurgery for Brain Metastases Serrata在脑转移瘤放疗后中枢神经系统放射性坏死治疗中的作用
Pub Date : 2023-03-01 DOI: 10.37549/aro1337
R. Upadhyay, H. Perlow, Evan M. Thomas, S. Beyer, R. Raval, J. Grecula, D. Blakaj, A. Chakravarti, W. Slone, P. Giglio, J. Elder
no other distant metastases. She underwent video-assisted thoracoscopic surgery (VATS) biopsy of parietal pleural nodules, which confirmed metastatic renal cell carcinoma. Baseline contrast-enhanced MRI of brain was negative for intracranial metastases. She was started on first-line systemic therapy with pembrolizumab and axitinib. Restaging scans revealed good response with improvement in small pulmonary nodules with minimal residual pleural thickening in the right lung base. About 6 months after initial diagnosis, the patient presented with headaches and left-sided neck pain. A brain MRI with and without contrast revealed interval development of a 1.5 × 1.4-cm enhancing nodule in the left frontal lobe with mild to moderate surrounding vasogenic edema and mass effect. She also had an MRI of the cervical spine, which demonstrated multilevel degenerative changes but no metastatic disease. She was started on a short course of tapering Abstract Radiation necrosis (RN) is a concerning late toxicity after radiation therapy for brain metastases. The management of RN primarily depends on the extent of edema on imaging and presence of symptoms. Oral corticosteroids are the mainstay of management; however, they are not optimal for long-term management because of multiple side effects and drug interactions. Boswellia serrata is an extract derived from Indian frankincense, which is available as an over-the-counter supplement, and has been traditionally used in the treatment of asthma, arthritis and colitis due to its anti-inflammatory properties. Recent data have reported the benefits of Boswellia on reducing cerebral edema. We discuss a case report involving a patient with brain metastases treated with stereotactic radiosurgery who developed early RN and had a good response with resolution of postradiation edema with the use of Boswellia.
没有其他远处转移。她接受了电视胸腔镜手术(VATS)对壁胸膜结节的活检,证实了转移性肾细胞癌。颅内转移瘤的基线增强MRI为阴性。她开始接受pembrolizumab和阿西替尼的一线全身治疗。静息扫描显示反应良好,肺部小结节改善,右肺基底部残留胸膜增厚最小。初步诊断后约6个月,患者出现头痛和左侧颈部疼痛。有对比剂和无对比剂的大脑MRI显示,左额叶有一个1.5×1.4厘米的增强结节,周围有轻度至中度血管源性水肿和肿块效应。她还做了颈椎的核磁共振成像,显示有多级别的退行性变化,但没有转移性疾病。她开始了一个短暂的减量过程摘要放射性坏死(RN)是脑转移放射治疗后一种令人担忧的晚期毒性。RN的治疗主要取决于影像学上水肿的程度和症状的存在。口服皮质类固醇是主要的治疗方法;然而,由于多种副作用和药物相互作用,它们不是长期治疗的最佳选择。Boswellia serrata是一种从印度乳香中提取的提取物,可作为非处方补充剂,由于其抗炎特性,传统上被用于治疗哮喘、关节炎和结肠炎。最近的数据报道了Boswellia在减少脑水肿方面的益处。我们讨论了一例涉及一名接受立体定向放射外科治疗的脑转移患者的病例报告,该患者早期出现RN,并通过使用Boswellia对放射后水肿有良好的缓解作用。
{"title":"Role of Boswellia Serrata in Management of CNS Radiation Necrosis After Radiosurgery for Brain Metastases","authors":"R. Upadhyay, H. Perlow, Evan M. Thomas, S. Beyer, R. Raval, J. Grecula, D. Blakaj, A. Chakravarti, W. Slone, P. Giglio, J. Elder","doi":"10.37549/aro1337","DOIUrl":"https://doi.org/10.37549/aro1337","url":null,"abstract":"no other distant metastases. She underwent video-assisted thoracoscopic surgery (VATS) biopsy of parietal pleural nodules, which confirmed metastatic renal cell carcinoma. Baseline contrast-enhanced MRI of brain was negative for intracranial metastases. She was started on first-line systemic therapy with pembrolizumab and axitinib. Restaging scans revealed good response with improvement in small pulmonary nodules with minimal residual pleural thickening in the right lung base. About 6 months after initial diagnosis, the patient presented with headaches and left-sided neck pain. A brain MRI with and without contrast revealed interval development of a 1.5 × 1.4-cm enhancing nodule in the left frontal lobe with mild to moderate surrounding vasogenic edema and mass effect. She also had an MRI of the cervical spine, which demonstrated multilevel degenerative changes but no metastatic disease. She was started on a short course of tapering Abstract Radiation necrosis (RN) is a concerning late toxicity after radiation therapy for brain metastases. The management of RN primarily depends on the extent of edema on imaging and presence of symptoms. Oral corticosteroids are the mainstay of management; however, they are not optimal for long-term management because of multiple side effects and drug interactions. Boswellia serrata is an extract derived from Indian frankincense, which is available as an over-the-counter supplement, and has been traditionally used in the treatment of asthma, arthritis and colitis due to its anti-inflammatory properties. Recent data have reported the benefits of Boswellia on reducing cerebral edema. We discuss a case report involving a patient with brain metastases treated with stereotactic radiosurgery who developed early RN and had a good response with resolution of postradiation edema with the use of Boswellia.","PeriodicalId":72265,"journal":{"name":"Applied radiation oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42930062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Applied radiation oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1